Current Opinion in Hematology

Papers
(The H4-Index of Current Opinion in Hematology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis68
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies47
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis46
Hormetic endoplasmic reticulum stress in hematopoietic stem cells44
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia24
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies24
Deficits in our understanding of natural killer cell development in mouse and human23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy19
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function18
Mechanisms of immunothrombosis in COVID-1918
Regulation and importance of factor VIII levels in hemophilia A carriers17
Disparities in acute myeloid leukemia treatments and outcomes17
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis16
Developmental regulation of primitive erythropoiesis16
The impact of obesity-induced inflammation on clonal hematopoiesis15
Congenital neutropenia: disease models guiding new treatment strategies15
The new world: hematopoietic stem cell transplant during a pandemic15
0.064181804656982